SARS-CoV-2 Spike RBD Variant B.1.1.248, His-Tag recombinant Protein

Please log in to see the special conditions of your institution.



+49 (0) 40 . 43 20 84 48 0


Product Overview, Sizes and Prices



Synonyms: Novel Coronavirus 2019, Recently identified in Brazil & Japan, with mutations K417T; E484K; N501Y

Source: HEK

Physical state: Liquid

Manufacturer:  Diaclone

Article No. Size Price  
715.H22.0BU 100µg on request

Please inquire for other vial sizes and custom vialing.



Product Details

This SARS-CoV-2 Spike RBD Variant B.1.1.248 spike protein was recently identified in Brazil & Japan, with mutations K417T; E484K; N501Y.


The protein is validated by ELISA with clinical positive serum samples.

  • Application: Immunoassays - Bioassays (Spike RBD Protein, active form)
  • Purity: >95% by SDS PAGE gel
  • Concentration: 1 mg/ml
  • Size: 100 µg - Other sizes and Bulk format available
  • Expressed in Mammalian cells (HEK293 cells)
  • Quality controls


Further new SARS-CoV-2 protein variants currently in development:








Usage: For research use only. Not for use in diagnostic or therapeutic procedures. Not for human use.


To buy SARS-CoV-2 Spike RBD Variant B.1.1.248, His-Tag please click on the Shopping List Symbol right from the indicated price. This will add the product to your Shopping List. You can then click on the button »Shopping List & Order Form« or the Shopping List Symbol in the top navigation to ask for a quote. We will send you your quote as soon as possible. Our offer will include institutional discounts where applicable.


All prices are net prices (excluding VAT). Final prices in our quote will contain VAT plus shipping costs if applicable. For further information please go to our Shipping page.


Errors, changes and availability excepted.




Payment Methods

Paying by bank transfer


We ship with UPS

Free shipping for orders above 500 € within Germany

This website uses cookies to store your Personal Shopping List. By using our website you accept the use of session cookies. Learn more
I accept all necessary cookies